SEPTInvestingStart Free

DYN 10-Q: SEC filing

Dyne Therapeutics

Filed with the SEC on · accession 0001818794-26-000012

DYN filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. Dyne Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, cash position, and operating expenses.

Summary of the filing

Dyne Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, cash position, and operating expenses. No single material corporate event is identifiable from the filing.

For details, click here →How to read a 10-Q →

Key details

FilerDyne Therapeutics, Inc.
Lender/credit facility counterpartyHercules Loan Agreement

✦ Ask GOAX AI about this filing — what it means for DYN, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for DYN?

Click here

Frequently asked questions

What did DYN file with the SEC on Nov 5, 2026?

DYN filed a 10-Q (SEC filing). Dyne Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial statements, cash position, and operating expenses. No single material corporate event is identifiable from the filing.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

Other DYN SEC filings

Get alerts when DYN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
DYN overviewDYN analysisDYN newsLatest SEC filings